Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Idrx Inc.
Sponsor

Idrx Inc.

United States 1250 South Road, 19426-2990, United States

About the sponsor

Idrx Inc. is focused on clinical research in metastatic and unresectable gastrointestinal stromal tumors (GIST), with work centered on advanced disease settings where treatment options remain limited.

  • Metastatic GIST
  • Unresectable GIST
  • Antitumor activity

The sponsor’s active program in this area reflects a therapeutic interest in targeted oncology for difficult-to-treat sarcoma subtypes.

About Specializations

Idrx Inc. runs clinical trials in conditions such as Gastrointestinal stromal tumour, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Gastrointestinal stromal tumour

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:[4-(Methyl-1H-Pyrazol-4-Yl)-Benzyl] (6[7-(3-Pyrrolidin-1-Yl-Propoxy)-Imidazo[1,2-A] Pyridin-3-Yl]-Pyrimidin-4-Yl]-Amine
  • Sponsor:Idrx Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.